Overall Survival and Second Primary Malignancies in Men With Metastatic Prostate Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0227552
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Nine-Year Prostate Cancer Survival Differences Between Aggressive Versus Conservative Therapy in Men With Advanced and Metastatic Prostate Cancer

Cancer
Cancer ResearchOncology
2018English

Predictive Factors of Response and Overall Survival in Patients With Castration-Resistant Metastatic Prostate Cancer Undergoing177Lu-Psma Therapy

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2015English

Increased Risk of Second Primary Hematologic and Solid Malignancies in Patients With Mycosis Fungoides: Impact on Overall Survival in Seer Registry

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Circulating Fibroblast-Like Cells in Men With Metastatic Prostate Cancer

Prostate
OncologyUrology
2012English

Predictors of Survival Outcomes in Native Sub Saharan Black Men Newly Diagnosed With Metastatic Prostate Cancer

BMC Urology
MedicineReproductive MedicineUrology
2017English

Prostate-Specific Antigen Decline After 4 Weeks of Treatment With Abiraterone Acetate and Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer

European Urology
Urology
2016English

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer

JAMA Oncology
Cancer ResearchOncology
2018English

MS17.03 Surveillance and Second Primary Malignancies in Lung Cancer Survivors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy